The APP/PS1/tau mice treated with rolipram for 10 days show a significant attenuation of anxiety‐ and depression‐like behaviors by increasing cAMP/PKA signaling and decreasing neuroinflammation.60 The gene discussed is MAPT; the disease is depressive symptom measurement.